Aesthetic Medical International Holdings Group (AIH) has a ROE of 183.16%, above the Healthcare sector average of -100.59%.
Get informed when a big investor buys or sells
+ Follow183.16%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
The latest ROE for AIH is 183.16%. That is above the Healthcare sector average of -100.59%. Investors often review this figure alongside Aesthetic Medical International Holdings Group's historical trend and sector peers before judging valuation or financial health.
Against Healthcare companies, AIH currently prints 183.16% for ROE, while the sector average sits near -100.59%. That is roughly 282.1% above the sector mean. Large gaps often invite a closer look at Aesthetic Medical International Holdings Group's growth, margins, and balance sheet.
Return on Equity shows how effectively Aesthetic Medical International Holdings Group converts resources into returns. At 183.16%, AIH may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting AIH's ROE (183.16%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Aesthetic Medical International Holdings Group's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.